Abstract
Genotoxic carcinogens form covalent bonds with proteins as well as with DNA. The adducts which result are useful for assessing exposure to the carcinogen, determining inter-individual differences in metabolism and other carcinogen processing, and perhaps in risk assessment. This commentary reviews the development of molecular dosimetry based on protein adducts and describes some of the principles involved. Also described are studies of the binding of bulky lipophilic carcinogens to proteins, which clearly indicate that a high degree of specificity is characteristic of many carcinogen-protein interactions. Studies which have been conducted with human populations are summarized and some proposals for future studies are made.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
